Cardiac Embryology
The care of children with heart disease has increasingly become a neonatal specialty. Fetal diagnosis of congenital heart defects (CHDs) is now routine. Reparative cardiovascular surgery is commonplace in the first month of life in select cases and is now undertaken in utero. Defects once considered inoperable, most notably hypoplastic left heart syndrome, can be treated, with greatly improved long-term results. In parallel with these clinical advances, there has been exciting progress in understanding the cellular and molecular basis of normal and abnormal cardiogenesis and the relationship of heart defects to other congenital defects. Nonetheless, the incidence of CHDs has not decreased,49 indicating much more work is required to find ways to prevent CHDs. The expansion in our understanding from combining clinical and basic science findings may lead us to better predict the severity and consequences of congenital heart defects and also lead to strategies for alleviating the consequences to children and adults.
Much of the current knowledge about cardiovascular development is based on studies of species other than humans, notably the chicken, quail, mouse, rabbit, fruit fly, and zebrafish. Remarkable similarities have been detected in molecular and cellular developmental mechanisms among these diverse species. Research on the developmental genetics of the fruit fly, for example, has made an impact on our basic understanding of genes important for vertebrate systems, including humans. In the other direction, information from clinics has been analyzed in detail in more easily accessible and manipulatable systems such as the fruit fly, zebrafish, chicken, or mouse. The distance between the bedside and the bench is getting shorter.
The mature heart is the product of gene expression driven by endogenous and exogenous influences. The developing heart manifests its morphologic and physiologic plasticity under stress. A detailed understanding of the effects of the factors that drive normal cardiogenesis is necessary for understanding the causes and consequences of abnormal development. Errors in cardiac morphogenesis involved with septation, valve formation, and proper patterning of the great vessels are responsible for most forms of congenital heart disease. Normal heart development requires precise timing for coordination of the complex three-dimensional contortions of tissues, but paradoxically, these tissues also have a remarkable capacity for regulation that allows compensation for mistakes. These adjustments can allow abnormal heart structures and functions to be compatible with life up to and even after birth, but complicates identification of the primary causes of cardiac anomalies.
It is possible to investigate cardiovascular development at various levels using a variety of disciplines: molecular biology, biochemistry, biomedical engineering, cell and tissue biology, genetics, physiology, and epidemiology. Significant results have emerged when information was shared across disciplines. For example, the hemizygous deletion in the elastin gene has been shown to be responsible for Williams syndrome (or Williams-Beuren syndrome), the autosomal dominant form of supravalvular aortic stenosis.39 Predictions about the clinical manifestations of this disease were elucidated after mutant elastin proteins were found in humans; existence of these mutant proteins was proposed based on knowledge about the protein structure provided by studies at the bench. In the reverse direction, analysis of the mutant human proteins in animal models, tissue culture, and other in vitro studies advanced understanding of the disease and the biochemistry and role of elastin in vascular cell signaling. These signaling pathways may become targets for therapy. The passage of information across these investigative levels has resulted in a remarkably productive synergy.
Overview of Normal Heart Development
The following description of human heart development, especially the earlier events, is synthesized from information provided by studies of animal models and human embryonic and fetal tissues. A timetable of selected events in human heart development is presented in Table 79-1.33,36,44 Figure 79-1 is a diagram depicting the major transitions in early mammalian heart development.47
TABLE 79-1
Developmental Landmarks in Cardiac Morphogenesis
Week | Days | Somites | Length (mm)* | Stage† | Developmental Events |
3 | 15 | VIII | (Primitive streak) | ||
16 | |||||
17 | |||||
18 | 1-3 | 1.5 | Blood islands in chorion, stalk, yolk sac | ||
19 | |||||
20 | 1 | 1.5 | Cardiogenic plate | ||
21 | 4 | Tubes (2) connect with blood vessels | |||
4 | 22 | 4-7 | 2 | X | Tubes fuse |
23 | X | Single median tube (first contractions), looping begins | |||
24 | 13-20 | 2.5-3 | XI | ||
25 | |||||
26 | 21-29 | 3.5 | XII | Cardiac loop | |
27 | Single atrium | ||||
28 | 25 | 4-5 | XIII | Bilobed atrium, primary AS begins growth | |
5 | 29 | 6-7 | XIV | IVS appears | |
30 | 28 | Primary AS continues growth (placental circulation begins) | |||
31 | 7-8 | XV | Ridges form inside outflow tract | ||
32 | Primary AS begins perforation formation | ||||
33 | 9-10 | XVI | |||
34 | XVII | Secondary AS begins to grow; primary AS has foramen secundum | |||
35 | 11-14 | AV cushions begin fusion (three-chambered heart) | |||
6 | 36 | Arterial (aortic arch) and venous morphogenesis begins | |||
37 | 14-16 | XVIII | IVS growing | ||
38 | |||||
39 | 17-20 | XIX | |||
40 | Septation of bulbus and ventricle, valve formation | ||||
41 | 21-23 | XX | IVS maturation continues, AV canal splits into two | ||
42 | |||||
7 | 43 | 22-24 | XXI | Beginning of separation of AV myocardial connection | |
44 | 25-27 | XXIII | (Fetal stages begin) | ||
45 | |||||
46 | |||||
47 | |||||
48 | |||||
49 | Membranous and muscular IVS is complete, resulting in four-chambered heart | ||||
24-40 | 210-360 | Birth and beginning of neonatal circulation |
AS, Atrial septum; AV, atrioventricular; IVS, interventricular septum.
†Roman numerals refer to Streeter horizons.
Data from Moore KL. The developing human: clinically oriented embryology. Philadelphia: Saunders; 1982; Pansky B. Review of medical embryology. New York: Macmillan; 1982; Sissman NJ. Developmental landmarks in cardiac morphogenesis: comparative chronology. Am J Cardiol. 1970;25:141.

The primordia of the heart are identified as bilaterally symmetric heart fields derived from the lateral plate mesoderm. These primordia migrate through the primitive streak between the ectoderm and endoderm layers to become symmetric mesoderm regions on either side of the primitive streak. These tissues fuse cranially to form a tubular structure comprising an inner layer of endocardium, a thick layer of extracellular matrix, and an outer layer of myocardium. This simple tube begins to contract rhythmically and grows differentially so that dilations (primordia of the heart chambers) and constrictions (primordia of the partitions between chambers) appear along its length. Later additions to the distal ends of the tubular heart form the outflow tract (OFT) and the sinus venosus. Dextral looping of the tube brings the venous caudal portion to a more dorsal position and to the left of the arterial cranial portion as septation of the tubular heart begins. The epicardium arises from tissue dorsal to the heart at the level of the atrioventricular (AV) junction and spreads over the outer surface of the myocardium as a layer of squamous epithelial cells and associated connective tissue during the early phase of septation.
The atrial chamber, arising from expansion of a caudal region, divides into two chambers by the growth of a crescentic ridge from the anterodorsal wall at the narrowest point of the atrial chamber. This ridge grows and fuses with the dorsal and ventral endocardial cushions, which are themselves growing and fusing with each other. Before the atrial septum completely closes, perforations in the ostium primum appear and coalesce in the dorsal portion of the septum to form a single opening: the ostium secundum later termed the foramen ovale. A second atrial septum subsequently grows to the right of the primary atrial septum; in conjunction with the primary atrial septum, it forms a one-way valve (right-to-left blood flow only) between the two atria in the fetus. This avenue of blood flow is permanently closed shortly after birth to complete atrial septation.
Ventricular septation is not complete at the time the primary atrial septum is formed. The ventricular septum results from the growth and remodeling of trabecular sheets, continues with expansion of the ventricular chambers, and ends with the fusion of several tissues, including endocardial cushions and the muscular septum, to form the membranous and muscular interventricular septum. The OFT septation is the result of growth and fusion of spiraling ridges that eventually divide the truncus into aortic and pulmonary tracts. The venous and arterial vessels (aortic arches) undergo differential degeneration, fusion, and growth to attain the mature structures.
The human heart has completed the major morphogenetic processes 8 weeks after fertilization. What follows is the completion of maturation of structures, growth, accumulation of cellular junctions at the intercalated discs, biochemical adjustments, and compensation for the changes in patterns of blood flow after birth, such as permanent closure of the foramen ovale of the atrial septum and closure and fibrosis of the ductus arteriosus.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

